Clarest Health, a leader in personalized medication management, has launched the next generation of Clarest Path. The medication intelligence platform combines an integrated data layer with a predictive intervention engine. It serves health plans and at-risk providers that need earlier visibility into medication-related risks. As a result, Clarest Path helps teams address risks before they affect patients and healthcare costs.
The platform supports health plans as they work to improve Star performance and patient outcomes. It also targets costs linked to medication non-adherence. In addition, Clarest Path brings medication data and clinical workflows together through one connected platform.
The unified platform addresses all five critical medication-related Star Ratings measures: CMR, Adherence, SUPD, COB, and Poly-ACh. At its core, Clarest Path uses a clinically validated, real-time machine learning engine. The engine continuously identifies and prioritizes risks across medication programs. Therefore, care teams can act before an adverse event occurs. They can also intervene before a situation requires an emergency response.
Clarest Path was developed by Clarest Health to assist patients in controlling their medications in advance. Priority is given to the prompt identification of danger as well as assistance of individuals in different stages of medical assistance. In addition, new technologies and professional medical knowledge are incorporated into the procedure.
The unified platform features five key medication measures within Star Ratings. These are CMR, Adherence, SUPD, COB, and Poly-ACh. The platform also helps care teams reduce avoidable healthcare utilization. It also helps members get better results.
“The rules around Star Ratings may still be evolving, but what makes for good medication management has not changed: catch risk early, stay with the patient, and follow through,” said Hammad Shah, chief executive officer at Clarest Health. “By bringing all medication-related measures under one roof, we are eliminating the confusion of siloed point-solutions and replacing it with continuous, personalized care that protects both member outcomes and plan performance.”
Connecting Medication Risk With Coordinated Care
Health plans increasingly need connected solutions instead of separate risk-management tools. Disconnected systems can treat risk as a static score. They can then pass that score between multiple vendors without coordinated action. Clarest Path takes a different approach by bringing these capabilities into one platform. The system continuously ingests data from fragmented member interactions. It then turns that information into a coordinated care journey.
The platform also works in collaboration with patients’ providers. Consequently, teams can address multiple care and quality requirements through fewer interactions. This connected approach can help plans manage drug spending more effectively. It can also support efforts to lower the total cost of care. Furthermore, it places pharmacy and quality teams closer to outcome management.
Case Study Demonstrates Medication Management Results
Medication non-adherence continues to create significant and preventable healthcare challenges. The issue remains especially important across the Medicare population. Patients managing several chronic conditions can face additional medication-related risks.
Such patients may be at risk for polypharmacy and gaps in care transitions. They may also experience communication failures between prescribers and other care teams. Social barriers can also make it harder to take medicines as prescribed.
Recently, Clarest Health rolled out an integrated Medication Therapy Management (MTM) and adherence program. The program participated in two Medicare Part D contracts.
The program resulted in an estimated $55 reduction in monthly costs per engaged member. It also created $3.8 million in combined program value. The results reflected a return of about 6.9x the plan’s investment in 2025.
In addition, the CMR completion rate was 25.6% higher than the prior-year pace. These results show how integrated medication management can support both clinical and financial objectives.
Clarest Path Develops Unified Medication Intelligence
Clarest Path marries artificial intelligence and machine learning with clinical workflows. Unlike technology-only platforms, it seeks to turn insight into direct interventions.
The platform leverages a real-time AI/ML engine to stratify risk and prioritize. It then supports interventions that can address those risks before costs rise or outcomes decline.
Clarest Path also draws from Clarest Health’s nationwide ecosystem. This includes long-term care pharmacies and at-home pharmacies. As a result, health plans and providers can support patients across different care settings.
The platform tracks patients from facilities to their homes and back again. This helps teams have more continuity throughout the medication management process.
Clarest Path Key Capabilities
Real-Time Risk Intelligence: Clarest Path utilizes a real-time AI/ML engine trained on 10 years of data. The engine continuously identifies and prioritizes emergent risks to care teams. It helps in developing care plans to tackle the risks identified. Rather than passing a risk score, the platform supports action around that risk.
Comprehensive Workflow Unification: The platform covers CMR, Adherence, SUPD, COB, and Poly-ACh. It also supports provider coordination and personalized fulfillment. Therefore, health plans can reduce dependence on multiple single-measure vendors. This connected model supports fewer handoffs and more coordinated care.
AI-Guided Clinical Interventions: Clarest Path leverages clinical intelligence with 3,000 recommendations. These recommendations are developed by pharmacists and clinicians. Nurses, pharmacists and other care-team members receive real-time scripting and dynamic recommendations. They also get AI-powered patient summaries.
These capabilities decrease the need to review charts extensively. And they help care teams have more personal patient interactions at the same time.
Easy Patient and Provider Engagement: The platform combines intelligent automation and human support. This approach assists patients in better meeting their medication needs. Problems could be refills, changes in medications or barriers to picking up prescriptions from the pharmacy.
Clarest Health’s team works proactively to help patients bridge these gaps. These efforts are enabled by electronic integrations across the healthcare system. Therefore, providers and care teams can coordinate better.
Closed-loop fulfillment: The pharmacy fulfillment system provided by Clarest Health seeks to fill the gaps in medication compliance. This capability is beneficial for elderly patients living at home and patients with complicated medication treatment plans. The platform connects the two functions of fulfillment and medication management resulting in a more complete treatment process. Overall, Clarest Path merges medication intelligence, clinical experience, AI, and pharmacy fulfillment.
Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.
News Source: Businesswire.com
